Clinical Trial Update: Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating aminolevulinic acid photodynamic therapy for HPV-positive low-grade cervical intraepithelial neoplasia (CIN1/LSIL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Low-grade Squamous Intraepithelial Lesions
• Papillomavirus Infections

Drugs mentioned

• aminolevulinic acid photodynamic therapy (aminolevulinic acid photodynamic therapy)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Cervical Intraepithelial Neoplasia, Low-Grade Squamous Intraepithelial Lesions | Phase 2 | Status: COMPLETED